Cargando…
RNAi Therapeutic Platforms for Lung Diseases
RNA interference (RNAi) is rapidly becoming an important method for analyzing gene functions in many eukaryotes and holds promise for the development of therapeutic gene silencing. The induction of RNAi relies on small silencing RNAs, which affect specific messenger RNA (mRNA) degradation. Two types...
Autores principales: | Fujita, Yu, Takeshita, Fumitaka, Kuwano, Kazuyoshi, Ochiya, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816685/ https://www.ncbi.nlm.nih.gov/pubmed/24275949 http://dx.doi.org/10.3390/ph6020223 |
Ejemplares similares
-
A novel platform to enable inhaled naked RNAi medicine for lung cancer
por: Fujita, Yu, et al.
Publicado: (2013) -
The Impact of Extracellular Vesicle-Encapsulated Circulating MicroRNAs in Lung Cancer Research
por: Fujita, Yu, et al.
Publicado: (2014) -
Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer
por: Fujita, Yu, et al.
Publicado: (2015) -
Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases
por: Fujita, Yu, et al.
Publicado: (2018) -
Development of Small RNA Delivery Systems for Lung Cancer Therapy
por: Fujita, Yu, et al.
Publicado: (2015)